Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Gynaecological Cancers Congress 2024

GSK - Paradigm shifts and improving outcomes for patients with dMMR/MSI-H endometrial cancer

Recent data on survival outcomes from anti-PD-(L)1 trials in primary A/R EC

Date

21 Jun 2024

Session

GSK - Paradigm shifts and improving outcomes for patients with dMMR/MSI-H endometrial cancer

Presenters

Sandro Pignata

Authors

S. Pignata

Author affiliations

  • Istituto Nazionale Tumori IRCCS - Fondazione G. Pascale, Napoli/IT

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Introduction

Presenter: Sandro Pignata

Session: GSK - Paradigm shifts and improving outcomes for patients with dMMR/MSI-H endometrial cancer

Resources:

Webcast

Panel discussion

Presenter: Andreia Fernandes

Session: GSK - Paradigm shifts and improving outcomes for patients with dMMR/MSI-H endometrial cancer

Resources:

Webcast

Panel discussion 2

Presenter: Andreia Fernandes

Session: GSK - Paradigm shifts and improving outcomes for patients with dMMR/MSI-H endometrial cancer

Resources:

Webcast

Q&A and closing remarks

Session: GSK - Paradigm shifts and improving outcomes for patients with dMMR/MSI-H endometrial cancer

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.